Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) ROI

AIM IMMUNOTECH INC. (AIM) ROI

  • 2026-06-30: ROI -95.22%.
  • 2026-03-31: ROI -209.43%.
  • 2025-12-31: ROI 263.01%.
  • 2025-06-30: ROI 1053.16%.

Complete source-backed roi history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical ROI

DateROI
2026-06-30-95.22%
2026-03-31-209.43%
2025-12-31263.01%
2025-06-301053.16%
2025-03-31-3174.95%
2024-12-31-456.75%
2024-09-30-423.97%
2024-06-30-320.92%
2024-03-31-420.57%
2021-03-31-19.43%
2020-12-31-22.74%
2020-09-30-18.25%
2020-06-30-22.74%
2020-03-31-26.35%
2019-12-31-59.72%
2019-09-30-63.06%
2019-06-30-112.65%
2019-03-31-163.79%
2018-12-31-121.37%
2018-09-30-113.26%
2018-06-30-71.52%
2018-03-31-63.38%

Annual ROI

DateROI
2025-12-31263.01%
2024-12-31-456.75%
2020-12-31-22.71%
2019-12-31-59.67%
2018-12-31-121.37%

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B